Time for Serum Albumin to Recover After Major Liver, Pancreas, and Bile Duct Surgeries and Its Role in Predicting Patient Outcomes

What this Trial Is About

Researchers are examining the time it takes for serum albumin levels to recover after major hepatobiliary and pancreatic surgeries. Albumin, a protein that decreases due to inflammation from surgery, may reflect surgical stress and recovery. The study aims to understand how albumin recovery relates to patient outcomes such as complications and hospital stay length, as current data on this recovery time is limited. This observational study focuses on patients undergoing these major surgeries to better predict recovery and risks after surgery. The study involves patients who have had major hepatobiliary or pancreatic surgeries, including a retrospective arm using data from 2010. No active treatment is administered as this is an observational study. Researchers will monitor albumin levels postoperatively to assess the time to albumin recovery and correlate this with various outcomes such as hospital stay duration, complications, intensive care use, and readmission rates. These measures will be tracked over 30 to 90 days after surgery. Participants will have their albumin levels monitored and clinical outcomes recorded to evaluate recovery from surgical stress. Researchers will use classifications like the Clavien Dindo system and the Comprehensive Complication Index to assess complications, along with ICU stays and readmission rates. The main focus is on how quickly albumin levels return to normal and its impact on hospital stay. The total follow-up period may extend up to 90 days to observe post-surgical recovery and outcomes.

Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries